MedPath

Effect of combined zinc and vitamin E supplementation in treatment of women with gestational diabetes mellitus

Phase 3
Conditions
Gestational diabetes mellitus.
Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium
Registration Number
IRCT20170513033941N56
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients with gestational diabetes mellitus.
Individuals aged 18 to 40 years.

Exclusion Criteria

overt diabetes mellitus
Taking any supplements before the intervention
Unwillingness to cooperate

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.
Secondary Outcome Measures
NameTimeMethod
itric oxide. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Malondialdehyde. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Glutathione. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Total antioxidant capacity. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Newborn's head circumference. Timepoint: Delivery time. Method of measurement: Tape.;Newborn's weight. Timepoint: Delivery time. Method of measurement: Scale.;Polyhydramnios. Timepoint: End-of-trial. Method of measurement: Sonography.;Newborn length. Timepoint: The first 24 h after birth. Method of measurement: Girth measuring tape.
© Copyright 2025. All Rights Reserved by MedPath